Table 1. Re-calculation of a meta-analysis of CVD mortality due to use of AST first presented by Nguyen et al ¹⁸.

		AST		Control			Risk ratio
Study	Median AST duration (months)	Events	Total	Events	Total	Weight (%)	M-H, Random, 95%CI
D’Amico et al, 2008	6	13	102	13	104	15.1	1.02 (0.50, 2.09)
Bolla et al, 2010	36	22	207	17	208	21.4	1.30 (0.71, 2.38)
Roach et al, 2008	4	31	224	26	232	32.7	1.23 (0.76, 2.01)
Denham et al, 2011	3–6	36	532	23	270	30.8	0.79 (0.48, 1.31)
Total (95% CI)			1065		814		1.06 (0.80,1.40)
Total events		102		79

Heterogeneity: I²=0% (P=0.55)

Test for overall effect: Z=0.40 (P=0.69)